Bluejay Diagnostics, Inc. BJDX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.75M | 3.93M | 3.91M | 3.96M | 3.94M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.33M | 6.97M | 6.92M | 6.98M | 6.72M |
| Operating Income | -7.33M | -6.97M | -6.92M | -6.98M | -6.72M |
| Income Before Tax | -7.27M | -6.90M | -6.85M | -6.85M | -6.74M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.27 | -6.90 | -6.85 | -6.85 | -6.74 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.27M | -6.90M | -6.85M | -6.85M | -6.74M |
| EBIT | -7.33M | -6.97M | -6.92M | -6.98M | -6.72M |
| EBITDA | -7.24M | -6.88M | -6.84M | -6.91M | -6.65M |
| EPS Basic | -34.74 | -52.84 | -98.88 | -136.13 | -1.35K |
| Normalized Basic EPS | -21.61 | -32.92 | -61.70 | -85.08 | -152.48 |
| EPS Diluted | -34.74 | -52.84 | -98.88 | -136.13 | -1.35K |
| Normalized Diluted EPS | -21.61 | -32.92 | -61.70 | -85.08 | -152.48 |
| Average Basic Shares Outstanding | 1.09M | 660.60K | 449.00K | 252.60K | 166.10K |
| Average Diluted Shares Outstanding | 1.09M | 660.60K | 449.00K | 252.60K | 166.10K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |